C12N 2770/24322
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2770/24322 (New viral proteins or individual genes, new structural or functional aspects of) appears on 97 US grants and 107 published applications in this corpus.
Search patents in C12N- Granted patents
- 97
- Published applications
- 107
- Assignees
- 75
- Inventors
- 218
- Latest grant
- 6 Sep 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 7 | 0 |
| 1999 | 5 | 0 |
| 2000 | 3 | 0 |
| 2001 | 6 | 0 |
| 2002 | 3 | 7 |
| 2003 | 5 | 7 |
| 2004 | 3 | 6 |
| 2005 | 3 | 7 |
| 2006 | 4 | 3 |
| 2007 | 3 | 4 |
| 2008 | 10 | 6 |
| 2009 | 3 | 11 |
| 2010 | 5 | 9 |
| 2011 | 1 | 11 |
| 2012 | 3 | 4 |
| 2013 | 4 | 4 |
| 2014 | 4 | 3 |
| 2015 | 5 | 3 |
| 2016 | 4 | 5 |
| 2017 | 3 | 4 |
| 2018 | 4 | 1 |
| 2019 | 2 | 1 |
| 2020 | 0 | 1 |
| 2021 | 2 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 4 |
| 2025 | 0 | 3 |
By publication year. Applications have been published since 2001.
Recent patents
- Recombinant vector comprising BiP fragment and preparation method of recombinant proteins using thereof6 Sep 2022US 11,434,496 B2Bioapplications Inc.
- Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped RNA viruses30 Mar 2021US 10,961,279 B2ISD Immunotech ApS
- Pestivirus23 Mar 2021US 10,954,491 B2Intervet Inc.
- Vaccine composition for classical swine fever from plant and manufacturing method thereof9 Jul 2019US 10,344,293 B2Bio-Applications, LLC
- Baculovirus display vectors and uses thereof8 Jan 2019US 10,172,931 B2Reber Genetics Co., Ltd.
- Bovine viral diarrhea virus immunogenic compositions and methods of use thereof23 Oct 2025US 2025/0325645 A1Kansas State University Research Foundation
- Immunostimulatory preparation and cosmetic, food, feed additive, and quasi-pharmaceutical product containing the immunostimulatory preparation18 Sep 2025US 2025/0288663 A1Japan Eco-Science Co., Ltd.
- Recombinant classical swine fever virus e2 protein with b/c domain swapping17 Jul 2025US 2025/0230194 A1Boehringer Ingelheim Vetmedica (China) Co., Ltd.
- Recombinant classical swine fever virus e2 protein24 Oct 2024US 2024/0350610 A1Boehringer Ingelheim Vetmedica (China) Co., Ltd.
- Mammalian cell line and method for producing soluble e2 recombinant antigen of classical swine fever virus using the same and application thereof27 Jun 2024US 2024/0209033 A1National Pingtung University of Science and Technology
Most cited
By later US patents
- Recombinant infectious non-segmented negative strand RNA virus156US 6,033,886 A2000
- NYVAC vaccinia virus recombinants comprising heterologous inserts137US 5,494,807 AVirogenetics Corporation · 1996
- Modified recombinant vaccinia virus and expression vectors thereof65US 5,762,938 AVirogenetics Corporation · 1998
- Alvac canarypox virus recombinants comprising heterlogous inserts56US 5,756,103 AVirogenetics Corporation · 1998
- Protein expression in baculovirus vector expression systems39US 6,555,346 B1Bayer Aktiengesellschaft · 2003